First-line PARP inhibitors (PARPi) with androgen receptor pathway inhibitors (ARPi) in metastatic castration-resistant prostate cancer (mCRPC): A systematic review and meta-analysis.

Authors :: Khan, Muhammad Ali
Naqvi, Syed Arsalan Ahmed
Imran, Manal
Channar, Aneeta
Saxena, Akshat
Raina, Ammad
Khakwani, Kaneez Zahra Rubab
Riaz, Zaryab Bin
Kase, Adam McLain
Humphreys, Mitchell R.
Moore, Cassandra N.
Orme, Jacob
Childs, Daniel S
Singh, Parminder
Bryce, Alan Haruo
Palmer, Jeanne M.
Riaz, Irbaz Bin
Source :: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p173-173, 235p
Publication Year :: 2024

Full Text Access

Tools